Clinical Trial Update: Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and acceptability of cabotegravir in HIV-uninfected women in KwaZulu-Natal, South Africa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)

Snippet

Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: Human Immunodeficiency Virus | Phase 2 | Status: WITHDRAWN